AEON Biopharma Inc

AEON14 Dec 2024
Healthcare
$0.71
-0.05 (-5.07%)
Lowest Today
$0.65
Highest Today
$0.75
Today’s Open
$0.71
Prev. Close
$0.71
52 Week High
$17.17
52 Week Low
$0.52
To Invest in AEON Biopharma Inc

AEON Biopharma Inc

Healthcare
AEON14 Dec 2024
-0.05 (-5.07%)
1M
3M
6M
1Y
5Y
Low
$0.65
Day’s Range
High
$0.75
0.65
52 Week Low
$0.52
52-Week Range
52 Week High
$17.17
0.52
1 Day
-
1 Week
+7.92%
1 month return
-3.17%
3 month return
-6.86%
6 month return
-51.08%
1 Year return
-88.47%
3 Years return
-93.01%
5 Years return
-
10 Years return
-

Market Status

Fundamentals
Market Cap
35.97 mln
PB Ratio
0
PE Ratio
0
Enterprise Value
51.94 mln
Total Assets
6.84 mln
Volume

Company Financials

Fund house & investment objective

Company Information
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and posttraumatic stress disorder. The company is based in Irvine, California.
Organisation
AEON Biopharma Inc
Employees
5
Industry
Biotechnology
CEO
Mr. Marc  Forth
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step